Rankings
▼
Calendar
HOWL FY 2020 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$41M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$777,000
Operating Income
-$22M
Net Income
-$15M
EPS (Diluted)
$-0.98
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$632,000
Balance Sheet
Total Assets
$96M
Total Liabilities
$7M
Stockholders' Equity
$89M
Cash & Equivalents
$93M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$777,000
-$463,000
-67.8%
Operating Income
-$22M
-$10M
-125.5%
Net Income
-$15M
-$11M
-35.9%
← FY 2019
All Quarters
Q1 2020 →